WeForNews | Latest News, Breaking News, News Updates Kerala Sex scandal : Nun's family threatened, Next hearing on Sep 24th | WeForNews | Latest News, Blogs
Connect with us

India

Kerala Sex scandal : Nun’s family threatened, Next hearing on Sep 24th

Published

on

Law

Sep 13: The Kerala police on Thursday has submitted the second affidavit in the Kerala High Court in connection with the Nun Rape Case, in a sealed cover. The police has sought more time for the probe into the case as nun’s family was offered money and were threatened. All related cases in the matter will be heard in the Kerala Court on 24th September 2018.

The Kerala High Court said the probe by the police against Franco Mulakkal, the bishop of the Roman Catholic Diocese of Jalandhar accused by a nun of raping her, is moving in the right direction.

Bishop Franco Mullakal of Jalandhar diocese, who has been accused by a nun of raping her, has been summoned by Investigative Officer on 19th September. Mullakal raised many hues and cry and the Judge said, ‘ There is nothing alarming at the manner in which the investigation is undergoing.”

 Sandhya Raju, counsel for the nun who was raped said  before the Kerala High Court “Money was offered to the members of the family and they are also being threatened.”

The court accepted the police’s plea that the department will file a fresh report after questioning the 54-year-old bishop. Police have asked Mullakal to appear before the investigating team on September 19 amid mounting pressure to initiate action against him.

“Let the police quiz him again. We will hear the case after this,” the court said.

Public Prosecutor told Kerala High Court, “Round the clock security has been provided to the victim since July 2018 at St Francis Convent.”

While hearing the petition seeking CBI inquiry into the Kerala Nun rape case, the  Court said, “CBI inquiry is not necessary at this point in time. We are not rejecting the petition but we will tag it with the main petition.”

Chief Justice, “You must show the patience which the victim has shown. We have noted that the police have seized a lot of documents which are in the custody of police now for examination.

The investigation is going across five states and seven districts of Kerala. Witnesses and evidence across these places are being examined

Judge asked, “Are you interested in arrest or interested in conviction?.”

“Steps should be taken to avoid intimidation of the people who are away,” Judge told Police

Cities

Delhi reports 51 cases of minor adverse events post vaccination

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Published

on

By

Covid 19 Vaccine

Hours after the Health Ministry announced on January 16 that India has reported no case of post-vaccination hospitalisation yet, 51 persons complained of minor adverse events in Delhi. Another person developed severe adverse event following immunization and had to be referred to the AEFI centre.

Out of a total of 4,319 healthcare and frontline workers who were vaccinated on Jnauary 16 in the National Capital, two healthcare workers at NDMC’s Charak Palika Hospital reported mild adverse event post-vaccination including mild tightness in the chest. They were kept under observation by AEFI team and discharged 30 minutes later after they felt at ease. The two other cases were reported from Northern Railway Central Hospital, of which one was referred to the AEFI centre, the Delhi government has informed.

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Beneficiaries from 11 states and union territories across India received Covishield or Covaxin shots on the first day of the vaccination drive, namely, Assam, Bihar, Delhi, Haryana, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Telangana, and Uttar Pradesh.

Follow our coverage of the coronavirus crisis here

Continue Reading

Health

Bharat Biotech to pay compensation if Covaxin causes side-effects

The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19

Published

on

By

COVAXIN Corona Covid vaccine

Hyderabad, January 16: Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company would pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

In the consent form to be signed by the vaccine recipients, Bharat Biotech said: “In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals.”

“The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” the consent form said.

In phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19. However, the clinical efficacy of the vaccine was yet to be established and it was still being studied in phase 3 clinical trials, the vaccine maker said.

“Hence it is important to appreciate that receiving the vaccine does not mean that other precautions related to COVID-19 need not be followed,” the consent form said.

According to an industry expert, the company is liable to pay compensation to people in case of serious side effects as the vaccine is being administered while in the clinical trial mode.

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode.

Meanwhile, Suchitra Ella, joint managing director, Bharat Biotech International Limited, on her Twitter account said: “Covaxin & Bharat Biotech is truly humbled & honoured to be of service to the nation & the fraternity of all first responders of covid who have served public health.” — PTI

Continue Reading

Cities

AIIMS security guard reports allergy post COVID vaccination, in hospital care

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

Published

on

By

Vaccine

New Delhi, January 16

A 22-year-old security guard at AIIMS, New Delhi reported allergic reaction and is learnt to be in intensive care, moments after the government said there was no post-vaccine hospitalisation.

The 22-year-old guard developed headache, rash, respiratory distress, tachycardia after vaccination. He is in ICU and his condition is stable, hospital sources said.

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

All beneficiaries vaccinated at AIIMS got indigenous COVAXIN.

Continue Reading
Advertisement

Most Popular